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Abstract
The introduction of β-hydroxy-α-amino acids (βHAAs) into organic molecules has received considerable attention as these
molecules have often found widespread applications in bioorganic chemistry, medicinal chemistry and biomaterial science.
Despite innovation of asymmetric synthesis of βHAAs, stereoselective synthesis to control the two chiral centres at Cα and
Cβ positions is still challenging, with poor atomic economy and multi protection and deprotection steps. These syntheses are
often operated under harsh conditions. Therefore, a biotransformation approach using biocatalysts is needed to selectively
introduce these two chiral centres into structurally diverse molecules. Yet, there are few ways that enable one-step synthesis
of βHAAs. One is to extend the substrate scope of the existing enzyme inventory. Threonine aldolases have been explored to
produce βHAAs. However, the enzymes have poor controlled installation at Cβ position, often resulting in a mixture of
diastereoisomers which are difficult to be separated. In this respect, L-threonine transaldolases (LTTAs) offer an excellent
potential as the enzymes often provide controlled stereochemistry at Cα and Cβ positions. Another is to mine LTTA homologues
and engineer the enzymes using directed evolution with the aim of finding engineered biocatalysts to accept broad substrates with
enhanced conversion and stereoselectivity. Here, we review the development of LTTAs that incorporate various aldehyde
acceptors to generate structurally diverse βHAAs and highlight areas for future developments.
Key points
• The general mechanism of the transaldolation reaction catalysed by LTTAs
• Recent advances in LTTAs from different biosynthetic pathways
• Applications of LTTAs as biocatalysts for production of βHAAs
Keywords L-threonine transaldolases (LTTAs) . β-Hydroxy-α-amino acids (βHAAs) . Stereoselective chemoenzymatic
synthesis . Natural product biosynthesis
Introduction and scope of the review
Nature often employs non-canonical amino acids that bear
new and different functional groups to tune the properties of
bioactive small molecules (Hibi et al. 2015). There are dozens
of knownmodifications to proteogenic amino acids, including
a wide variety that bears a hydroxyl group at the β-carbon. β-
Hydroxy-α-amino acids (βHAAs) are an important class of
compounds, the majority of which contain two chiral centres
at Cα and Cβ position, resulting in four possible diastereoiso-
mers (Ashford and Bew 2012). They are valuable constituents
of medicinally important compounds and complex natural
products (Hibi et al. 2015). For instance, L-threo-3,4-
dihydroxyphenylserine (Droxidopa) 1 (Fig. 1) is a currently
used therapeutic for the treatment of Parkinson disease
(Maruyama et al. 1996; Hauser et al. 2016).βHAAs have also
been used as intermediates in the biosynthesis of β-lactones
such as obafluorin 2 (Fig. 1) (Schaffer et al. 2017; Scott et al.
2017). L-threo-p-nitrophenylserine and its derivative are the
key components of amino alcohol antibiotics, chlorampheni-
col 3 (Seiple et al. 2014), its synthetic derivatives
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5 (Fig. 1) (Lu et al. 2008); β-hydroxytyrosine and β-
hydroxyphenylalanine residues are found in clinically active
glycopeptide antibiotics, such as vancomycin 6 (Fig. 1) (Yim
et al. 2014). Nucleotide-containing βHAA is the crucial motif
of the nucleoside antibiotic natural products 7–9 (Fig. 1)
(Barnard-Britson et al. 2012; Cai et al. 2015; Ushimaru and
Liu 2019). βHAAs are also common synthetic precursors to
β-lactams and aziridine carboxylic acid derivatives in synthet-
ic chemistry and to chiral bisoxazoline ligands for metal ca-
talysis (Masruri et al. 2012).
These diverse applications underlie a broad interest in un-
derstanding βHAA production and utilization in nature.
Accordingly, several methods have been devised for the
asymmetric syntheses of βHAAs including asymmetric aldol
reaction (Sugiyama et al. 2002 and Singjunla et al. 2013),
sharpless asymmetric dihydroxylations (Masruri et al. 2012),
stereoselective electrosynthesis using trans-metal Schiff base
complexes (Levitskiy et al. 2019) and numerous others. The
main challenge is the control of the relative and absolute ste-
reochemistry of the asymmetric carbons in the current trend of
sustainable development.
Compared to non-enzymatic synthesis, an attractive alter-
native is enzymatic synthesis of βHAAs via a one-step pro-
cess under mild conditions as a means of potentially more
atom-economic and greener. There have been considerable
attentions that are focused on those promising biotransforma-
tion strategies for asymmetric synthesis of βHAAs. Nature
has evolved different enzymatic routes to produce these useful
compounds. Free amino acids can undergo stereo-specific and
-selective Cβ hydroxylation, as illustrated by the non-heme
Fe-dependent hydroxylation of homotyrosine in the biosyn-
thesis of echinocandins (Hüttel. 2021). Another common bio-
synthetic strategy is for an amino acid to be loaded onto a non-
ribosomal peptide synthetase (NRPS), whereupon a P450 en-
zyme catalyses Cβ hydroxylation of an aminoacyl-S-enzyme
intermediate en-route to a peptide natural product as observed
in the biosynthesis of vancomycin 1 (Tailhades et al. 2020).
Threonine aldolases (TAs), which catalyse a reversible
chemical reaction of cleavage of threonine into glycine and
acetaldehyde, have been reported as such biocatalysts using
various aldehydes and glycine as substrates to generate useful
βHAAs (Fesko 2016). However, the poor enantioselectivity
at Cβ hampers their further application as side products are
generated. In contrast, there is a remarkable set of pyridoxal-
5′-phosphate (PLP)-dependent enzymes, L-threonine
transaldolases (LTTAs), which catalyse retroaldol cleavage
of L-threonine (Thr) and a subsequent aldol-like addition into
an aldehyde to form a new side chain, setting the stereochem-
istry of the Cβ−OH group. It is worth noting that phylogenetic
analysis suggested that LTTAs are evolutionary distinct from
L-threonine aldolases (LTAs) and SHMTs (Scott et al. 2017;
Wu et al. 2020).
This review surveys the recent advances of LTTAs discov-
ered in the biosynthetic pathways as potential biocatalysts,
highlighting the unique biochemical transformations and their
substrate promiscuity. Particular emphasis is placed on ex-
ploring the existing LTTA inventory for the production of
structurally diverse βHAAs. Furthermore, bioengineering of
Fig. 1 β-hydroxy-α-amino acids
(βHAAs) serve as building
blocks for many biological active
chemicals and pharmaceutical
drugs
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such enzymes will certainly advance our abilities to engineer a
suitable biotechnologically viable catalyst for βHAA produc-
tion. Other PLP-dependent enzymatic reactions discovered
from natural product biosynthesis can be found in the recent
review (Du and Ryan 2019). Another family of transaldolases
from the pentose phosphate pathway, catalysing the reversible
transfer of a dihydroxyacetone moiety between ketose donors
and aldose acceptors (D-glyceraldehyde-3-phosphate, or D-
erythrose-4-phosphate), was summarized in a review
(Samland et al. 2011). Therefore, this group of transaldolases
will be out of the scope in the current report.
Although the first LTTA, 4-fluorothreonine transaldolase
(FTase), was identified in 2001 (Murphy et al. 2001), it was
not until 11 years later in 2012 that a second LTTA was
identified (Barnard-Britson et al. 2012). Since then, five new
LTTA homologues have been discovered during the biosyn-
thetic studies of various bioactive natural products, coincided
with the advanced genome sequencing technology during the
last decade. It is noteworthy that while FTases are didomain
LTTAs, newly discovered LTTAs are single-domain en-
zymes. Automated annotation of the sequenced genomes has
miscategorized many LTTA-like open reading frames (ORFs)
in microbial genomes as serine hydroxymethyltransferase
(SHMT)-like enzymes (Scott et al. 2017). However, these
LTTA-like ORFs share low homologues (25–35% aa identity)
to SHMTs. Therefore, new LTTA homologues with improved
kinetics and broad substrate specificity could be identified and
characterized through conserved genomic mining of biotech-
nological purpose for asymmetric synthesis of βHAAs. This
review will serve as a compendium to communities of micro-
biologists, organic chemists, natural product chemists, bio-
chemists, synthetic biologists, and many others interested in
the subject.
The general mechanism of LTTAs
All of the LTTA enzymes utilize PLP as the cofactor. The
catalytic cycle starts and ends with the same PLP cofactor
form (the internal aldimine 10), which is derived from trans-
amination and heterolytic cleavage to maintain the
carbanionic intermediates (Richard et al., 2009). The internal
aldimine structure consists of an imine linkage between the
amino group of a lysine residue from the enzyme and the
aldehyde carbon of free PLP. Then, within the interaction of
L-Thr, a geminal diamine intermediate 11 is formed which
finally leads to the PLP:external aldimine 12 allowing sub-
strate binding and product release (Fig. 2). Additionally, the
proton in the external aldimine can transfer (or is shared) be-
tween oxygen in the pyridine ring and imine nitrogen forming
two tautomeric isoforms, enolimine 12 and ketoenamine 12a
separately. This transformation shows specific maximal ab-
sorbance values at 335 nm for enolimine 12a and 425 nm
for ketoenamine 12 when analysed by ultraviolet-visible
(UV-Vis) spectroscopy.
The PLP:external aldimine 12 is the crucial intermediate
for all LTTAs.Meanwhile, the efficiency of the PLP enzymat-
ic reaction is predominately dependent on the heteroaromatic
pyridine ring. The electrophilicity of the C4 of the external
aldimine is enhanced because of the protonated pyridinium
nitrogen, the resonance and hydrogen bonding of the hydroxyl
group, leading to an ‘electron sink’. Therefore, the protonated
imine nitrogen can withdraw electrons from the substrate. The
π-conjugation of the pyridine ring delocalizes and stabilizes
the net-negative charge of external aldimine. Due to the elec-
tronic delocalization energy, the stereochemical rearrange-
ment of σ bonds is activated by a π system, forming the
Dunathan intermediate 12b (Fig. 2b). The deprotonation of
hydroxyl group at Cβ of L-Thr residue results in a retroaldol
cleavage between the Cα-Cβ bond, promoting the bond-
breaking process of the perpendicular bond of the pyridine
ring 13a (Fig. 2b). As a consequence, the heterolytic cleavage
happens, and the Cα hybridization changes generate the
resonance-stabilized ubiquitous quinonoid intermediate 13
which displays specific maximal absorbance values at 495
nm. However, the quinonoid intermediate has not always been
observed by UV-Vis spectroscopy in many the PLP-
dependent reactions, suggesting that they may be extremely
short lived or transient. A subsequent aldol-like addition into
an aldehyde forms a new side chain 14, setting the stereo-
chemistry of the Cβ-OH group to yield new L-threo-α-
hydroxy-β-amino acids 15 after hydrolysis (Fig. 2a). It is
worth noting that LTTAs are evolutionarily divergent from
TAs as such the first half of the biochemical pathway of
LTTAs processes a retroaldol reaction, significantly different
from TAs.
Discovery of L-Thr transaldolases
from the biosynthetic pathways of natural
products
The discovery of the didomain 4-fluorothreonine
transaldolases (FTases)
Fluorine has emerged as a privileged element in medicinal
chemistry as well as in agrochemistry and materials science
(O’Hagan and Deng 2015). Fluorine substitutions are now
considered a standard strategy for modulating the properties
of chemical leads, despite that environmental contamination
by organofluorines is an issue of major concern due to their
persistence to biodegradation (Moreira et al. 2018). While
many chemical methods of selective synthesis of
organofluorines have been developed, it is attractive to con-
sider biotransformation approaches to selectively access novel
organofluorine chemicals, rather than using challenging
3509Appl Microbiol Biotechnol (2021) 105:3507–3520
chemical methods (Wu et al. 2020). Fluorinated NPs are rare,
mainly due to the highest heat hydration of fluoride in water
which makes fluoride a poor nucleophile. As a result, there are
only a handful of fluorinated natural products discovered by
organic chemists in natural product inventory. 4-
Fluorothreonine (4-FT) 5 is the only fluorinated amino acid
natural product discovered thus far. It was found to be a co-
occurrent metabolite with another fluorinated toxic,
fluoroacetate (FAc) 16, in the culture broth of the soil bacte-
rium Streptomyces cattleya in 1986 (Fig. 3a) (Sanada et al.
1986). O’Hagan and co-workers have conducted the seminal
work on elucidation of the fluorometabolism in S. cattleya
(D e ng e t a l . 2 0 0 4 ) . T h e y d emon s t r a t e d t h a t
fluoroacetaldehyde (FAd) 17 is the precursor of 4-FT
(Hamilton et al. 1997; Nieschalk et al. 1997; Moss et al.
2000), but glycine is not directly contributed to the 4-FT bio-
synthesis (Hamilton et al. 1998) in their early isotopic label-
ling studies, suggesting that the biotransformation of FAd 17
to 4-FT 5 is not descended from a classical aldolase reaction.
In 2001, the enzyme, 4-fluorothreonine transaldolase (4-
FTase), responsible for the production of 4-FT, was purified
from S. cattleya (Murphy et al. 2001). Biochemical analysis
using a combination of isotopic labelling experiments and
GC-MS analysis demonstrated that this wild-type enzyme ac-
tually catalyses a PLP-dependent cross-over transaldolation
reaction between FAd and L-Thr to give 4-FT and acetalde-
hyde as shown in Fig. 3a . The hal lmark of the
fluorometabolism studies is the discovery of the first native
fluorination enzyme, fluorinase (FlA), which catalyses C-F
bond formation between fluoride ion and S-adenosyl-L-
Fig. 2 a A generic mechanism of the transaldolation reaction catalysed by LTTAs. b The schematic representation of Dunathan intermediate 12a and
quinonoid intermediate 13a
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meth ion ine (SAM) 18 to genera te 5 ′ - f luoro-5 ′ -
deoxyadenosine 19 (O’Hagan et al. 2002; Dong et al. 2004).
19 is the first committed fluorinated intermediate in the 4-FT
and FAc biosynthetic pathway. Sequence analysis of the
cosmid DNA containing the flA gene indicated that the
gene-encoded FTase is not in the close proximity of flA
(Huang et al. 2006). To identify and clone the gene encoding
FTase, degenerate PCR primers were designed based on MS-
MS amino acid sequencing of FTase purified from S. cattleya.
Subsequent chromosomal walking strategy allowed identifi-
cation of a 1905 bp open-reading frame (orf). The encoded
gene product contains 634 amino acids (aa), composed of two
domains. The larger domain (S-domain) in the N-terminal
shares ~44% sequence identity with SHMTs from archaea
and thermophilic bacteria, while the smaller one (A-domain)
in the C-terminal displays homology (~28% aa identity) with
bacterial ribulose-1-phosphate-4-epimerase (Deng et al.
2008). It appears that FTase has a hybrid construction with
key binding motifs from these distinct enzymes. The flFT
gene was introduced into the model strain, S. lividans TK24,
for overexpression. Although the enzyme expression level
was low, incubation of recombinant enzyme with L-Thr and
FAd 17 generated 4-FT 5 as monitored in 19F-NMR. In vitro
pathway reconstitution indicated that fluoride ion can be
converted to 4-FT involving five overexpressed enzymes, in-
cluding recombinant fluorinase and FTase (Deng et al. 2008).
Inactivation of flFT in S. cattleya resulted in the sole produc-
tion of fluoroacetate (Zhao et al. 2012), further confirming the
role of FTase in 4-FT biosynthesis.
The genome sequencing efforts of the second decade of the
twenty-first century have revealed that another four actinomy-
cete strains encode the flA genes, suggesting that these four
new strains may have capacity to produce fluorometabolites
(Deng et al. 2014; Huang et al. 2014; Wang et al. 2014). Of
particular relevance here is the strain isolated from a Ghanaian
soil sample, Streptomyces sp. MA37. In culture, the organism
had the capacity to biosynthesise 4-FT 5 and FAc 16, as well
as a range of other minor fluorometabolites (Ma et al. 2015;
Wu et al. 2020). The flFT homologues encoding the last step
of 4-FT biosynthesis are in close proximity to the correspond-
ing flA homologue, in line with expectation. This is not the
case for S. cattleya, where flFT is located on the megaplasmid
pSCATT (1.8 Mbp in length) and the flA gene is on the chro-
mosome of S. cattleya (Zhao et al. 2012).
More recently, the overexpression of flFT homologous
gene (flFTMA) from Streptomyces sp.MA37 in different hosts
was carried out for detailed biochemical analysis (Wu et al.
2020). Among three Streptomyces hosts (S. lividans TK24,
Fig. 3 a The biosynthetic pathways of 4-fluorothreonine and
fluoroacetate, highlighted with the first committed enzymatic step in the
pathway of the fluorination enzyme. The fluorinase (FlA) in Streptomyces
cattleya and Streptomyces sp. MA37 (MA37). b FTaseMA from MA37,
the close homologue of the original FTase identified in S. cattleya,
displays broad substrate specificity toward various aldehyde acceptors.
c The proposed mechanism of the dehydration of FAd hydrate 17a to
FAd aldehydic form 17 catalysed by the second small domain of
FTaseMA for the transaldolation reaction
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S. lividans 66 and S. albus J-1074), the S. lividans 66 recom-
binant variant gave the highest production of 4-FT while the
least activity was found in S. lividans TK24 recombinant
strain. The recombinant protein (FTaseMA) was purified to
near homogeneity as a bright yellow protein with UV absor-
bance maxima at 335 and 425 nm, in which the enolimine
peak at 325 nm is dominant. The stoichiometry between
bound PLP and the protein was estimated to be 1:1.
Incubation of the purified recombinant enzyme with L-Thr,
FAd and PLP resulted in the production of 4-FT 5, demon-
strating that the recombinant protein is functional (Wu et al.
2020).
FTases are unusual enzymes in that they use FAd 17 as a
substrate, which is heavily hydrated in water as FAd hydrate
17a (Fig. 3c) (Cobb et al. 2004). As a result, the enzymes
appear to evolve specific ability of accelerating the transfor-
mation of FAd hydrate 17a to the aldehyde form 17 or FAd
enol form 17b for the next transaldolation reaction (Fig. 3c).
This is in line with the hybrid construction of functional
FTases that have a small domain (A domain) homologous to
aldolase/epimerase possibly involving the dehydrate reaction.
Structural prediction of this A domain suggested good struc-
tural similarity with the metal-dependent class II aldolases
(Wu et al. 2020). The active sites of these aldolases normally
contain a catalytic tetrad of Glu-His-His-His, the latter three
His residues of which coordinate a divalent metal acting as a
Lewis acid type catalyst. The general mechanism of these
aldolases involves the first Glu residue directing proton trans-
fer of the aldol to generate an enediol intermediate, coordinat-
ed by the bound zinc. Examination of the predicted structure
of the aldolase/epimerase domain of FTaseMA suggested a
catalytic tetrad, Glu573-His551-His553-His598, with the es-
sential residue of Asn484 that may position Glu573 residue
towards the active site through hydrogen bonds. Indeed, ele-
mental analysis of FTaseMA demonstrated that the stoichiom-
etry of the bound zinc and the enzyme was estimated to be 1:1
(Wu et al. 2020). Alanine-scanning mutagenesis of the three
His and Asn residues significantly reduced the production of
4-FT 5, suggesting that these four residues are important (Wu
et al. 2020). The mutated FTaseMA variant, in which Glu573
was changed to Ala, however, caused the instability of the
purified protein for further biological evaluation.
FTaseMA displays considerable substrate plasticity.
Although FTaseMA cannot accept D-allo-threonine, D-threo-
nine or glycine or alanine or leucine as substrates, consistent
with the previous studies of FTase from S. cattleya (Murphy
et al. 2001), it can use L-Ser as substrate, albeit with low
conversion of 4-FT as monitored in 19F-NMR. Most of the
characterized LTTAs were found to accept L-Thr as the only
retroaldol donor (Wu et al. 2020). Strikingly, the enzyme can
also utilize L-allo-Thr as substrate with nine-fold less efficien-
cy than the natural substrate L-Thr, a clear difference com-
pared to other LTTAs. FTaseMA also accepts a range of
electrophilic aldehyde acceptors with different functionalities,
such as chloroacetaldehyde, glycolacetaldehyde, propanal,
isobutyraldehyde, phenylacetaldehyde, when L-Thr was used,
to generate different βHAAs, suggesting that this enzyme
could be used as a potential versatile biocatalyst to produce
various βHAAs (Wu et al. 2020). Of particular interests here
is glycolacetaldehyde which is heavily hydrated in water.
Seventy per cent of glycolacetaldehyde in the aqueous solu-
tions exists as a diol form while only 4% is the aldehyde form
(Collins and George 1971), further demonstrating the unusual
ability of FTaseMA to dehydrate the diol of hydrated alde-
hyde species.
LTTAs from the biosynthetic pathways of nucleoside
antibiotic natural products
Several lipopeptidyl nucleoside antibiotics, such as A-90289s
8 from Streptomyces sp. SANK 60405 (Fujita et al. 2011), and
caprazamycins 9 from Streptomyces sp. MK730-62F (Igarashi
et al. 2005), contain highly modified furanose motifs (Figs. 1
and 4). Previous isotopic labelling studies suggested that a C–
C bond forming event, possibly via an aldol mechanism, oc-
curs extending the carbon chain at C-5′ of the canonical nu-
cleoside to C6 or longer chain length of a so-called high-car-
bon nucleoside scaffold (Winn et al. 2010).
With the advance of genome sequencing technology in the
last decade, the biosynthetic gene clusters (BGCs) of these
nucleoside antibiotics have been identified for characteriza-
tion (Barnard-Britson et al. 2012). Bioinformatics analysis of
these clusters revealed that they shared an orf, putatively an-
notated as SHMT-like enzyme. This analysis was in line with
the prediction of an aldol reaction that the putative SHMT
ORFsmay catalyse a biotransformation of Gly and nucleoside
5′-aldehyde 21 to yield the corresponding high-carbon nucle-
oside intermediates during the biosynthesis of these
antibiotics.
Heterologous expression of lipK, encoding a putative
SHMT in the BGC of A-90289s in S. lividan TK24, resulted
in a soluble recombinant protein which contains a character-
istic UV absorption maximum of 415 nm, corresponding to a
typical holo PLP-dependent enzyme (Fig. 2a). This UV ab-
sorption was abolished in a LipK variant where Lys235 was
changed to Ala, demonstrating that Lys235 is the key aa res-
idue for the catalytic cycle (Barnard-Britson et al. 2012).
Tests on the activity of LipK with 21 and Gly or other L-
amino acids revealed that only incubation of L-Thr resulted in
the appearance of a new compound as observed in HPLC
analysis. The identity of the new compound was confirmed
to be the βHAA containing glycine uracil 22 as evidenced by
high-resolution MS and comprehensive 1D and 2D NMR
analysis, in comparison to synthetic materials. The absolute
stereochemistry of 22 was determined to be (5′S, 6′S) through
the diagnostic J coupling value (JH6′-H5′ = 5.0 Hz) of the
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derivatised synthetic and enzymatic 22. The enzyme displays
restricted substrate specificity and only accepts L-Thr as the
substrate. Unlike FTases, LipK is a single-domain LTTA.
Further conserved genomic analysis indicated the occurrence
of LipK homologues, suggesting that L-Thr transaldolation
reaction may be more common than previously anticipated.
LipK represents the second confirmed LTTA and the first
subgroup of L-Thr:uridine-5′-aldehyde (UA) transaldolase to
catalyse the biotransformation of βHAA-containing nucleo-
sides, providing a new biotechnological platform to prepare
βHAA-containing sugar previously difficult to be
synthesized.
The second LipK-like LTTA, CapH, was identified in the
BGC of capuramycin-type antibiotics A-500359s (Cai et al.
2015). Characterization of recombinant CapH revealed that
CapH displays a similar biochemical property compared to
LipK with restricted substrate specificity towards L-Thr. It
has remained to be determined whether LipK or CapH utilises
other nucleotide aldehydes except UA.
LTTA from the pathway of β-lactone antibiotic
The antibiotic natural product obafluorin 2 (Fig. 1) belongs to
the chemical class of β-lactones, consisting of strained four-
membered rings, closely related to β-lactam family of antibi-
otics, such as penicillin. Obafluorin 2 contains an interesting
βHAA motif, (R)-β-hydroxy-p-nitro-L-homophenylalanine
(β-OH-p-NO2-homoPhe) 23. In 2017, the corresponding
BGC (oba/obi) of obafluorine 2 was identified in the produc-
er, Pseudomonas fluorescens, by two research groups simul-
taneously (Schaffer et al. 2017; Scott et al. 2017).
Bioinformatics analysis suggested that one of the orfs in the
BGC encodes a putative bacterial SHMT albeit low aa identity
(25%). Overexpression of obiH (obaG) in E. coli resulted in
the purification of the recombinant protein with unusual pink
colour (Scott et al. 2017; Kumar et al. 2021). Biochemical
assays coupled with isotopic labelling experiments demon-
strated that ObiH (ObaG) is a new LTTA that catalyses the
t r a n s a l d o l a t i o n b e tw e e n L - T h r a n d p - n i t r o -
phenylacetaldehyde 24 to generate a single stereoisomer of
β-OH-p-NO2-homoPhe with a yield of 55–59% (Scott et al.
2017).
ObiH (ObaG) displays a UV/Vis spectrum characteristic of
PLP-dependent proteins, comprising absorption maxima at
340 nm and 390 nm that correspond to the internal
ketoenamine 10 and enolimine 10a (Fig. 2a), respectively
(Scott et al. 2017). The pink colour of ObiH attributing the
UV absorption at 512 nm is correlated to the unusual internal
quinonoid 10b (Fig. 2a), which is inactive state of the enzyme
(Kumar et al. 2021). Exposing ObiH in the UV led to the rapid
photoablation of the 515-nm peak and a temporary increase at
340 nm, followed by decrease of 340 nm band and increase of
415 nm band, indicative of an isomerization between the
enolimine 10a and ketoenamine 10 of the cofactor, respective-
ly. Addition of L-Thr led to the formation of external glycyl
quinonoid intermediate 13 that is remarkably persistent with a
half-life of ~3 h, suggesting that ObiH catalyses the retro-aldol
cleavage of L-Thr in the reaction cycle. The long lifetime of
this glycyl quinonoid intermediate 13 would enable the en-
zyme reactivity with non-native aldehyde substrates for po-
tential biocatalyst development.
ObiH displays considerably good substrate promiscuity to-
wards aldehyde acceptors, phenylacetaldehydes, various ali-
phatic and extended aryl aldehydes as well as a range of aro-
matic aldehydes (Kreitler et al. 2019). For example, incuba-
tion of phenylacetaldehyde with ObiH led to a single stereo-
isomer, (2S)-amino-(3R)-hydroxy-4-phenylbutanoate 26a,
while the reaction with benzaldehyde was less efficient lead-
ing to two products of L-threo and L-erythreo-phenylserine
26b in a ratio of 1:2 and poor overall yield (>20%) (Fig. 5b)
(Kre i t le r e t a l . 2019) . Assay of an α -branched
isobutyraldehyde with ObiH resulted in the production of a
single stereoisomer, (2S,3R)-β-hydroxy-Leu 26c, a βHAA
that is difficult to be chemically constructed involving multi-
ple methods (Fig. 5b) (Kreitler et al. 2019). These results
suggested that ObiH and its homologues hold a potential for
Fig. 4 LipK and CapH are two LTTAs catalysing the transaldolation between L-Thr and uracil 5′-aldehyde 21 in the biosynthetic pathways of
lipopeptidyl nucleoside antibiotic natural products
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high diastereoselectivity depending on the substrate aldehydes
for the synthesis of enantiomerically pure L-threo-β-
hydroxy-α-amino acids.
The first crystal structure of LTTA was reported in 2021
(Kumar et al. 2021). ObiH (PDB number: 7K34) crystallized
as a homodimer (Fig. 5c), with an extension of the C-terminus
forming the dimer interface, consistent with other members of
the fold-type I superfamily of PLP-dependent enzymes (Eliot
and Kirsch 2004). The ObiH active site lies at the dimer inter-
face, with most of the key residues contributed from a single
unit (Kumar et al. 2021). Sequence alignment with other
LTTAs and SHMTs and structural information revealed that
Lys234, Arg366, His131, Tyr55 and Asp204 in the case of
ObiH (Fig. 5d) are highly conserved and are in the close
proximity of the PLP cofactor in the active site (Kumar et al.
2021). The pyridine ring of PLP is stacked with His 131, and
the PLP phosphate is buried with extended H-bond networks,
including two to Tyr55 and Asn268 from the partner subunit.
Asp204 forms hydrogen bonds to the pyridine nitrogen of
PLP, thereby increasing the electrophilicity of pyridinium
moiety. Mutational analysis indicated that Asp204 is essential
for the catalysis (Kumar et al. 2021).
LTTA from the biosynthetic pathway of thioheptose
nucleoside antibiotic natural products
Albomycins 7 are sulphur-containing sideromycin antibiotics,
which have intriguing structures consisting of a 6′-amino-4′-
Fig. 5 a ObiH (ObaG) catalyses a transaldolation between L-Thr and p-
nitro-phenylacetaldehyde 24 in the biosynthetic pathway of theβ-lactone
antibiotic natural product, obafluorine 2. b ObiH displays considerable
substrate flexibility towards various aryl and aliphatic aldehydes. c The
structure of ObiH, the first structure of LTTA, indicating that ObiH forms
a dimer (PDB access number: 7K34). Individual monomers are coloured
in blue (chain A) and cyan (chain B). d The active site residues of ObiH
are shown in sticks while the Lyn-bound PLP is shown in orange.
Hydrogen bonds are shown as pink dashes. The active site of ObiHwould
allow targeted engineering approaches to further improve the efficiency
of the transaldolation reactions catalysed by LTTAs in a broad context.
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thioheptose nucleoside 27 and an iron-chelating ferrichrome
siderophore that are linked via amide linkage to an L-Ser res-
idue (Fig. 6). Unlike lipopeptidyl nucleoside antibiotics such
as A90289s that contain D-ribose and L-amino acid residues in
the high-carbon nucleoside scaffold, albomycins has the D-
configuration (6′R) of the α-amino acid and the D-xylo-con-
figuration (3′R) of the furanose ring in the thioheptose core
which is rare occurrence found in nature. Bioinformatics anal-
ysis suggested that the corresponding BGC of albomycins
contain an orf (ambH), the gene product of which encodes
an LTTA-like enzyme that was proposed to catalyse the
transaldol reaction of L-Thr and 5′-oxo-4′-thioxylofuranose
nucleoside 27 to form the C′5-C′6 bond in 28 (Fig. 6a).
However, biochemical analysis demonstrated that 5′-oxo-
D-thioribose nucleoside 29 is the bona fide substrate of recom-
binant AmbH (Ushimaru and Liu 2019). AmbH catalyses a
regio- and stereo-selective transaldol reaction between L-Thr
and 29 to yield the thioheptose core with a D-ribofuranose ring
and an L-amino acid moiety 30, followed by the epimerization
of the L-amino acid to generate D-amino acid catalysed by
another PLP-dependent racemerase/epimerase AmbD to pro-
vide 28c. The D-thioribose ring to D-xylofuranose counterpart
28a is likely to be mediated by the radical SAM epimerase
AmbJ based on the gene deletion and complementation ex-
periments (Fig. 6b). The latter two epimerization events
catalysed by AmbD and AmbJ appear to be essential for con-
ferring the antimicrobial activity of albomycins despite no
major structural alterations (Ushimaru and Liu 2019). AmbH
displays considerable substrate plasticity toward 3′R-epimer
of 29, D-xylose-based nucleoside aldehyde 27 (Fig. 6a), but
the enzymatic products lost stereoselectivity, providing a mix-
ture of stereoisomers (Ushimaru and Liu 2019). The insertion
of a sulphur atom into the D-ribofuranose ring during the bio-
synthesis of albomycins has remained to be determined.
Fig. 6 AbmH catalyses the transaldolation reaction between L-Thr and a very unusual thioribofuranose aldehyde substrate, followed by two
epimerization events catalysed by a radical SAM AmbJ and PLP-dependent epimerase AmbD to finally install the thiopentose moiety in albomycins
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Discovery of LTTA homologue as biocatalysts
The discovery of the single-domain LTTAs in the biosynthe-
sis of natural products facilitates a conserved genomic ap-
proach with the aim of identifying new LTTA homologues.
Given the importance of βHAAs and difficulty of construct-
ing enantiomer of βHAAs, there has been a considerable at-
traction to utilising LTTA homologues as biocatalysts to pro-
vide a single-step synthesis of βHAAs under the mild condi-
tions with high stereoselectivity.
This is the case of PsLTTA from a Pseudomonas strain,
which has 99% sequence identity to ObiH (Xu et al. 2019).
Biochemical analysis demonstrated that PsLTTA accepts L-
Thr as the donor substrate among Thr isomers but consumes a
wide range of aromatic aldehydes with various substituents in
o, p, m position in the aromatic ring as acceptors (Fig. 7).
Among these aldehyde acceptors, PsLTTA is able to mediate
p-methylsulfonyl-benzaldehyde 31b and L-Thr to produce L-
threo-p-methylsulfonylphenylserine 32 with a high conver-
sion rate and a high de value. It is worth noting that 32 is the
key intermediate for synthesis of thiamphenicol and
florfenicol. In an optimised condition, the whole cell contain-
ing overexpressed recombinant PsLTTA provided an excel-
lent conversion of 67.1% with almost perfect stereoselective
ratio of 94.5%. Synthesis of 32 was also conducted in a
100-mL scale of whole-cell biotransformation, first demon-
strating that PsLTTA could be utilised as a robust biocatalyst
for one-step preparation of βHAAs.
Directed evolution of mutated LTTA
homologue with enhanced capacity
One-step stereoselective enzymatic synthesis of βHAAs has
already attracted a considerable attention as this method offers
better atomic economy under mild conditions with few by-
products generated compared to chemical synthesis.
Although PsLTTA showed the potential to catalyse the
asymmetric synthesis of 32, the overall productivity was mod-
erate, preventing the enzyme to be used as viable biocatalysts.
There are two factors that influence the catalytic efficiency.
Firstly, PsLTTA catalyses a reversible reaction depending on
the concentrations of substrates and products. The accumula-
tion of acetaldehyde may inhibit the forward transaldolation
reaction. Secondly, the aldehyde donors are not the natural
substrate of PsLTTA, resulting in low conversion and possi-
bly less stereoselectivity. Therefore, it would be desirable to
create an enzymatic system that consists of an engineered
PsLTTA with an improved activity towards aldehyde accep-
tors and other enzymes to eliminate the accumulation of
acetaldehyde.
Directed evolution has been proven to be a powerful
method for improving biocatalyst’s activities (Packer
and Liu 2015). The key to apply directed evolution is
to develop a high throughput screening (HTS) method
(Ye et al. 2018). To this end, Xu et al. developed a
coupled enzymatic reaction that can be used as the
HTS (Xu et al. 2020). Firstly, they applied error-prone
PCR method. Overexpression of PCR-mutated genes in
E. coli and the whole-cell assays in 96-well plate with
the reaction cocktail including PLP, aldehyde acceptor
and L-Thr were carried out. In the reaction supernatants,
alcohol dehydrogenase from Acetobacter pasteurianus
(ApADH) was added to transform acetaldehyde to eth-
anol and convert NADH to NAD+, the latter activity of
which can be assessed by monitoring the reduction of
NADH at 340 nm (Fig. 8). More than 4000 colonies
were screened. As a result, the double-point PsLTTA
variant (PsLLTTAM2) where Asn35 and Cys57 were
changed to Ser and Asn, respectively, was found to
have the maximal enhanced production of the target
βHAA with about 2.1-fold increase compared to wild-
type PsLTTA in the whole-cell assays. Subsequently,
PsLLTTAM2 was purified for biochemical characteriza-
tion. The apparent catalytic efficiency (kcat/Km) of
PsLLTTAM2 was 7.2-fold higher than the one for
Fig. 7 A ObiH homologue,
PsLTTA, catalyses a promiscuous
transaldolation to generate
various phenylserine derivatives
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wild-type PsLLTTA. It is worth noting that such two
mutations in PsLLTTA are consistent with the assess-
ment of the structure of ObiH (Kumar et al. 2021) that
Asn35 is in the active site of the enzyme and that
Cys57 is within a highly mobile loop.
To further improve the yield of βHAA produced by
PsLLTTAM2, Xu et al (Xu et al. 2020) developed a regener-
ation cycle of NADH coupling with the third enzyme, formate
dehydrogenase from Candida boidinii (CbFDH), to convert
NAD+ back to NADH using formic acid as substrate (Fig. 8).
Such an acetaldehyde elimination system significantly im-
proved the titre of 32 by 4-fold (61.3 mM) compared to the
one without the acetaldehyde elimination system in the whole-
cell studies (Xu et al. 2020). Finally, an engineered E. coli
chassis was generated, which contains three genes,
psLLTTAM2, cbFDH and apADH. The titre of 32 from this
engineered strain was further up to 101.7 mM, 8.8-fold in-
crease compared to the single system of PsLLTTA. The ben-
efit for this synthetic biology approach is that the biotransfor-
mation generates ethanol as the by-product. However,
the high concentration of accumulated ethanol may in-
hibit the growth of this engineered E. coli, resulting in
low productivity of βHAAs in turn in the industrial
setting. Therefore, it may be worthy considering using
other microbial chassis with high tolerance of ethanol
production in the future development.
Conclusion and future perspectives
Although the first LTTA was discovered almost two decades
ago, the catalytic potential of this group of enzymes was only
assessed during the last decade, coincident with the advanced
genome sequencing technology. Much is still needed to ex-
pand the scope of LTTA biocatalysts for asymmetric synthesis
of industrially important βHAAs. It is exciting to fully use the
existing enzyme inventory to accommodate new chemistries
for biotechnologically viable βHAA synthesis. Within this
limited pool of identified enzymes, some LTTAs display great
substrate flexibility toward aldehyde acceptors with consider-
ably good stereoselectivity. However, the overall productivity
of the βHAAs is not yet desirable as a viable biocatalyst. As a
complement to this, we should also turn our attention to pro-
tein engineering to enhance the activities of the promising
enzyme candidates. This was exemplified by the recent HTS
method which has set a framework for directed evolution of
LTTAs (Fig. 8).
Another potential exciting development is to turn our at-
tention to nature for inspirations by discovering new βHAA-
containing entities through natural product programmes and
new LTTAs with broad substrate specificity, better kinetics,
high regio- and stereo-selectivity and good tolerance towards
reaction conditions (i.e. organic solvents, temperatures) by
genomic mining strategy (Fig. 8). It should be noted that the
Fig. 8 Directed evolution and high throughput screening development enable the discovery of a PsLTTA variant with higher enantioselectivity and
productivity, followed by synthetic biology approach to create an engineered E. coli chassis for βHAA production.
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majority of LTTAs was identified from two bacterial species,
actinomycetes and pseudomonas, in the current enzyme in-
ventory. Protein motif analysis (Bailey et al. 2009) combined
with the available structure data of ObiH (Kumar et al. 2021)
suggested that LTTAs contain unique conserved motifs, in-
cluding F58, W68 and F70 in the mobile loop of ObiH, and
H324 and Q325 which form extensive hydrogen bond net-
work with the residues, H207 and R366, in the active site of
ObiH (Fig. 9). This information could serve as guidance for
future LTTA mining. Therefore, efforts directed towards
LTTA candidates from other microbial genus will certainly
offer a promising opportunity of discovering a biotechnolog-
ically viable biocatalyst for βHAA synthesis.
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